Associate Professor of Neurology
Director of Multiple Sclerosis Research
Director of Medical Student Education for Clinical Neurology
Phone: (412) 692-4609
Specialized Areas of Interest
Autoimmune disease that affect the nervous system.
Galen W. Mitchell, MD, maintains a clinical practice primarily specializing in autoimmune diseases and cares for patients in the clinic and on the inpatient and consult services during the year.
In his role as researcher, Dr. Mitchell conducted several clinical trials this year. They included evaluating the effects of a monoclonal antibody against an adhesion molecule utilized with or without Avonex® to see if the monoclonal antibody offers an additional treatment benefit. He was the primary investigator on a trial of Avonex® alone compared with Avonex® in combination with oral methotrexate, intravenous methylprednisolone, or both in patients with relapsing-remitting multiple sclerosis who have breakthrough disease on Avonex® monotherapy. He served as primary investigator on a study comparing the current dosage of Betaseron® to that of a double dose. Dr. Mitchell is just starting trials comparing the addition of cladribine to beta-interferon in the treatment of MS as well as several new oral medications and novel injectable drugs.
Dr. Mitchell conducted grand rounds as well as seminars at research and educational symposia, both nationally and internationally, providing information for primary care physicians, scientist and neurologists. He conducted a series of lectures for the Neurology residents on autoimmune diseases and on evidence-based medicine. As director of medical student education, he served on several committees, including the Neuroscience Clerkship Design Committee, Medical Student Clinical Skills Course Design Committee, Student Promotions Committee, Department of Neurology Education Committee and the Curriculum Committee. He continued teaching the 3rd year students on neurology emphasizing the entire neurological evaluation process and treatment of patients with neurological disease. He also taught a course to the 1st year medical student entitled “The Neurological Evaluation.”
During the next year, Dr. Mitchell will continue his clinical duties and research studies with the addition of new research projects. He also plans to continue teaching at local, national and international levels, speaking about evidence-based medicine, MS and its immune mechanisms and treatment. Through these endeavors, he will represent the Department of Neurology and give it more national recognition. Dr. Mitchell will also continue to serve on numerous education committees as well as teach the medical students and neurology residents.
Dr. Mitchell's publications can be reviewed through the National Library of Medicine's publication database.
American Board of Psychiatry and Neurology
Professional Organization Membership
American Academy of Neurology